| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 5e-05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.39 | 0.004 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |